chondroitin sulfate sulphate sulfate, chondroitin sulfate | Injectran solution for in / mouse. the introduction of 100 mg / ml 2 ml 10 pcs.

Release form

The solution for i / m administration is transparent, colorless or with a slightly yellowish tint.

Indications

Degenerative degenerative diseases of the joints and spine:

- peripheral osteoarthritis of the joints

- intervertebral osteochondrosis and osteoarthritis.

To accelerate bone marrow formation in fractures.

Contraindications

-. hypersensitivity to chondroitin sulfate

- bleeding, bleeding tendency

- thrombophlebitis

- pregnancy

- lactation period (breast-feeding should be discontinued during treatment)

- children's age (data on efficacy and safety are not available).

Use during pregnancy and lactation

Use of the drug Injectran during pregnancy is contraindicated. If the drug is used during breastfeeding, breast-feeding should be discontinued.

Special instructions

It is recommended that doses be increased under the supervision of a physician for patients with overweight, peptic ulcer or duodenal ulcer, while taking diuretics, and also at the beginning of treatment, if necessary, accelerate the clinical response.

In case of allergic reactions or hemorrhage, treatment should be discontinued.

Pediatric use

Data on the efficacy and safety of chondroitin sulfate in children are currently not available.

Effect on ability to drive vehicles and mechanisms

In the recommended dose range, the effect on the concentration of attention and the speed of psychomotor reactions has not been established. When taken in high doses, caution is advised when driving vehicles, working with machinery, and engaging in other potentially hazardous activities that require an increased concentration of attention and speed of psychomotor reactions.

Composition

1 ml:

chondroitin sodium sulfate 100 mg.

Excipients: sodium disulfite - 2 mg, methyl parahydroxybenzoate - 0.5 mg, 1M sodium hydroxide solution - up to pH 6.0-7.5, water d / i - up to 1 ml.

Dosage and administration of

V / m, 1 ml every other day. With good tolerance, the dose is increased to 2 ml, starting with the fourth injection. The course of treatment is 25-35 injections. If necessary, after 6 months, a second course of treatment is possible. The duration of repeated courses of treatment is determined by the doctor.

For the formation of bone marrow, the course of treatment is 3-4 weeks (10-14 injections every other day).

Side effects of

The following disorders are possible when using the drug in individuals with hypersensitivity to the drug.

From the side of the immune system: allergic reactions, angioedema.

From the skin and subcutaneous fat: skin rash, itching, erythema, urticaria, dermatitis.

From the alimentary system: dyspeptic phenomena.

Local reactions: redness, itching, hemorrhage are possible at the injection site.

Drug interaction

It is possible to enhance the action of indirect anticoagulants, antiplatelet agents and fibrinolytics, which requires more frequent monitoring of blood coagulation when used together.

It exhibits a synergistic effect when used simultaneously with glucosamine and other chondroprotectors.

Overdose of

No cases of overdose of Injectran have been reported.

Symptoms: Presumably that when the daily dose is exceeded, an increase in the manifestations of the side effect of the drug is possible.

Treatment: symptomatic treatment.

Storage Conditions

The product should be stored out of the reach of children, protected from light, at a temperature not exceeding 25 РC.

The Expiration of

is 3 years.

active substance

Chondroitin sulfate

Prescription conditions from

pharmacies Prescription

lekarstvennaja form

Solution for